Literature DB >> 32016039

The prognostic significance of preexisting diabetes in patients with surgically treated renal cell carcinoma: the ongoing debate.

Ho Won Kang1, Yong-June Kim1.   

Abstract

Entities:  

Year:  2019        PMID： 32016039      PMCID： PMC6976486          DOI： 10.21037/atm.2019.09.131

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  15 in total

1.  Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma.

Authors:  Grégory Verhoest; David Veillard; François Guillé; Alexandre De La Taille; Laurent Salomon; Clément Claude Abbou; Antoine Valéri; Eric Lechevallier; Jean-Luc Descotes; Herve Lang; Didier Jacqmin; Jacques Tostain; Luca Cindolo; Vincenzo Ficarra; Walter Artibani; Luigi Schips; Richard Zigeuner; Peter F Mulders; Arnaud Mejean; Jean-Jacques Patard
Journal:  Eur Urol       Date:  2006-12-08       Impact factor: 20.096

2.  Diabetes Mellitus as an Independent Predictor of Survival of Patients Surgically Treated for Renal Cell Carcinoma: A Propensity Score Matching Study.

Authors:  Hakmin Lee; Cheol Kwak; Hyeon Hoe Kim; Seok-Soo Byun; Sang Eun Lee; Sung Kyu Hong
Journal:  J Urol       Date:  2015-06-09       Impact factor: 7.450

3.  Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis.

Authors:  Madhur Nayan; Shreya Jalali; Anil Kapoor; Antonio Finelli; Alan So; Ricardo Rendon; Rodney H Breau; Luke T Lavallee; Simon Tanguay; Daniel Heng; Jun Kawakami; Naveen S Basappa; Georg Bjarnason; Frederic Pouliot; Robert J Hamilton
Journal:  Urol Oncol       Date:  2019-07-05       Impact factor: 3.498

4.  Diabetes and kidney cancer outcomes: a propensity score analysis.

Authors:  Madhur Nayan; Antonio Finelli; Michael A S Jewett; David N Juurlink; Peter C Austin; Girish S Kulkarni; Robert J Hamilton
Journal:  Endocrine       Date:  2016-11-04       Impact factor: 3.633

5.  Multi-institutional analysis of localized renal cell carcinoma that demonstrates the impact of diabetic status on prognosis after nephrectomy.

Authors:  Yun-Sok Ha; Won Tae Kim; Seok-Joong Yun; Sang-Cheol Lee; Wun-Jae Kim; Yong Hyun Park; Seok Ho Kang; Sung-Hoo Hong; Seok-Soo Byun; Yong-June Kim
Journal:  Ann Surg Oncol       Date:  2013-08-02       Impact factor: 5.344

6.  Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma.

Authors:  Ho Won Kang; Sung Pil Seo; Won Tae Kim; Seok Joong Yun; Sang-Cheol Lee; Wun-Jae Kim; Eu Chang Hwang; Seok Ho Kang; Sung-Hoo Hong; Jinsoo Chung; Tae Gyun Kwon; Hyeon Hoe Kim; Cheol Kwak; Seok-Soo Byun; Yong-June Kim
Journal:  Int J Clin Oncol       Date:  2017-08-08       Impact factor: 3.402

Review 7.  Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.

Authors:  Bethany B Barone; Hsin-Chieh Yeh; Claire F Snyder; Kimberly S Peairs; Kelly B Stein; Rachel L Derr; Antonio C Wolff; Frederick L Brancati
Journal:  JAMA       Date:  2008-12-17       Impact factor: 56.272

8.  Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC).

Authors:  Michela de Martino; Carmen V Leitner; Christoph Seemann; Sebastian L Hofbauer; Ilaria Lucca; Andrea Haitel; Shahrokh F Shariat; Tobias Klatte
Journal:  BJU Int       Date:  2014-06-12       Impact factor: 5.588

9.  The impact of type 2 diabetes on the outcome of localized renal cell carcinoma.

Authors:  Thomas Höfner; Martin Zeier; Gencay Hatiboglu; Christian Eisen; Gita Schönberg; Boris Hadaschik; Dogu Teber; Stefan Duensing; Andreas Trumpp; Markus Hohenfellner; Sascha Pahernik
Journal:  World J Urol       Date:  2013-12-27       Impact factor: 4.226

10.  The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.

Authors:  Wan-Shui Yang; Puthiery Va; Freddie Bray; Shan Gao; Jing Gao; Hong-Lan Li; Yong-Bing Xiang
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.